Advanced Specialty Care for Kids

Leadership in Pediatric Care


Sharing discoveries for all children.

Kids are Our Mission

With more than 250 physicians in dozens of specialties, our teams provide expert care for our patients and engage in research that will help to create healthier tomorrows for all children.

Some highlights of our programs include:

Our pediatric neurosurgery program, led by internationally recognized neurosurgeon George Jallo, M.D., is one of the largest in the Southeast.

Our patients have opportunities to access the latest treatments through clinical trials, including more than 150 active clinical studies for cancer and blood disorders in the past fiscal year.

We were the first certified pediatric treatment center in Florida to offer CAR-T therapy to treat children with B-cell precursor acute lymphoblastic leukemia.

Overall, we have more than 400 active research studies, and Johns Hopkins All Children’s faculty applied for or were granted 27 patents in the past fiscal year.


Opened to its first patient enrollments in 2007, Kids-DOTT is a landmark randomized clinical trial on the duration of anti-clotting medication therapy for venous thromboembolism (VTE) in patients under 21 years old.

Experts in machine learning and artificial intelligence are working with physicians in a range of medical specialties on new tools that aim to continuously improve patient outcomes by harnessing the power of data and analytics.

Cannon was born at 22 weeks and after a long road — 11 months in the hospital and 12 surgeries — he’s home with his family and celebrated his first birthday.

Henry and his family traveled thousands of miles so he could receive specialized care from Dr. George Jallo, who leads the pediatric neurosurgery team, which has world-renowned skill with brain and spinal tumors.

Researchers at Johns Hopkins All Children’s Hospital published a study that investigated the factors that contribute to blood loss during scoliosis surgery.

A project at the hospital is making better-quality pediatric data more available to researchers throughout the Johns Hopkins Health System.

Johns Hopkins All Children’s Hospital was the first certified treatment center in Florida to offer a cutting-edge cellular immunotherapy for advanced leukemia in children and young adults.

Johns Hopkins All Children's Hospital is a Magnet® designated hospital, the highest recognition a hospital can receive for nursing excellence and high-quality patient care.

Connect With Us

Learn more about research and innovation at Johns Hopkins All Children’s.

You can also explore Our Services to learn more about all the programs and services available from our specialists.